FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783204350> ?p ?o ?g. }

• W2783204350 endingPage "68" @default.
• W2783204350 startingPage "68" @default.
• W2783204350 abstract "INTRODUCTION: Sudden cardiac arrest (SCA) is the most common cause of death in patients with coronary artery disease. Mostly, ventricular tachycardia (VT) and ventricular fibrillation (VF) are the underlying aetiology of SCA, which is claimed to be successfully treated by a novel therapy, a wearable cardioverter defibrillator (WCD, LifeVest®). The assessment, performed within the European Network for HTA (EUnetHTA), aimed to provide valid data on clinical effectiveness and safety of the WCD. Furthermore, the project intended to elicit patients views on aspects regarding their cardiac disease and the WCD therapy as well as to identify neglected outcomes. METHODS: A synthesis of evidence on the basis of a systematic literature search in Medline via Ovid, Embase, the Cochrane Library, and the Centre for Reviews and Dissemination (CRD) databases was performed. The search was complemented by citation tracking and handsearch. A face-to-face semi-structured focus group interview was performed with five cardiac disease patients in the scoping phase. RESULTS: Since no prospective controlled trials were found, no assessment of effectiveness could be performed. With regard to safety, five prospective studies were included, but the quality of the body of evidence was very low. Adverse events (AEs) reported were skin rash/itching (6 percent), false alarms (14 percent), palpitations/lightheadedness/fainting (9 percent) and discontinuation due to comfort/lifestyle issues (16-22 percent). Serious adverse events (SAEs) were inappropriate shocks (0-2 percent) and unsuccessful shocks (0-.7 percent). Frequency of SAEs leading to death was 0-.3 percent. Patients of the focus group reported that experiencing a sense of security was crucial to them. The WCD therapy was not considered an option for weeks or months, due to expected restrictions in living a ‘normal’ and secure life. CONCLUSIONS: No statement can be made about the device effectiveness – further research is needed. More data and more adequate reporting of AEs and SAEs are needed in order to establish the device safety. In particular, more data is needed for risk stratification of high risk patients in order to further narrow down the wide range of indications for the WCD use." @default.
• W2783204350 created "2018-01-26" @default.
• W2783204350 creator A5012073269 @default.
• W2783204350 creator A5026291179 @default.
• W2783204350 creator A5027713178 @default.
• W2783204350 creator A5045016972 @default.
• W2783204350 creator A5050676983 @default.
• W2783204350 creator A5064339323 @default.
• W2783204350 creator A5089058322 @default.
• W2783204350 date "2017-01-01" @default.
• W2783204350 modified "2023-09-27" @default.
• W2783204350 title "PP002 Sudden Cardiac Arrest: Wearable Cardioverter-Defibrillator Therapy" @default.
• W2783204350 doi "https://doi.org/10.1017/s0266462317001994" @default.
• W2783204350 hasPublicationYear "2017" @default.
• W2783204350 type Work @default.
• W2783204350 sameAs 2783204350 @default.
• W2783204350 citedByCount "1" @default.
• W2783204350 countsByYear W27832043502022 @default.
• W2783204350 crossrefType "journal-article" @default.
• W2783204350 hasAuthorship W2783204350A5012073269 @default.
• W2783204350 hasAuthorship W2783204350A5026291179 @default.
• W2783204350 hasAuthorship W2783204350A5027713178 @default.
• W2783204350 hasAuthorship W2783204350A5045016972 @default.
• W2783204350 hasAuthorship W2783204350A5050676983 @default.
• W2783204350 hasAuthorship W2783204350A5064339323 @default.
• W2783204350 hasAuthorship W2783204350A5089058322 @default.
• W2783204350 hasConcept C126322002 @default.
• W2783204350 hasConcept C177713679 @default.
• W2783204350 hasConcept C197934379 @default.
• W2783204350 hasConcept C2775935837 @default.
• W2783204350 hasConcept C2776331378 @default.
• W2783204350 hasConcept C2776403943 @default.
• W2783204350 hasConcept C2776818218 @default.
• W2783204350 hasConcept C2777706214 @default.
• W2783204350 hasConcept C2778213512 @default.
• W2783204350 hasConcept C2778550298 @default.
• W2783204350 hasConcept C2781005686 @default.
• W2783204350 hasConcept C2993353509 @default.
• W2783204350 hasConcept C71924100 @default.
• W2783204350 hasConceptScore W2783204350C126322002 @default.
• W2783204350 hasConceptScore W2783204350C177713679 @default.
• W2783204350 hasConceptScore W2783204350C197934379 @default.
• W2783204350 hasConceptScore W2783204350C2775935837 @default.
• W2783204350 hasConceptScore W2783204350C2776331378 @default.
• W2783204350 hasConceptScore W2783204350C2776403943 @default.
• W2783204350 hasConceptScore W2783204350C2776818218 @default.
• W2783204350 hasConceptScore W2783204350C2777706214 @default.
• W2783204350 hasConceptScore W2783204350C2778213512 @default.
• W2783204350 hasConceptScore W2783204350C2778550298 @default.
• W2783204350 hasConceptScore W2783204350C2781005686 @default.
• W2783204350 hasConceptScore W2783204350C2993353509 @default.
• W2783204350 hasConceptScore W2783204350C71924100 @default.
• W2783204350 hasIssue "S1" @default.
• W2783204350 hasLocation W27832043501 @default.
• W2783204350 hasOpenAccess W2783204350 @default.
• W2783204350 hasPrimaryLocation W27832043501 @default.
• W2783204350 hasRelatedWork W1987728658 @default.
• W2783204350 hasRelatedWork W2009982819 @default.
• W2783204350 hasRelatedWork W2043663677 @default.
• W2783204350 hasRelatedWork W2059050869 @default.
• W2783204350 hasRelatedWork W2097093034 @default.
• W2783204350 hasRelatedWork W2127272700 @default.
• W2783204350 hasRelatedWork W2223850997 @default.
• W2783204350 hasRelatedWork W2783204350 @default.
• W2783204350 hasRelatedWork W3025351748 @default.
• W2783204350 hasRelatedWork W4295779879 @default.
• W2783204350 hasVolume "33" @default.
• W2783204350 isParatext "false" @default.
• W2783204350 isRetracted "false" @default.
• W2783204350 magId "2783204350" @default.
• W2783204350 workType "article" @default.